https://www.pharmaceutical-technology.com/news/ The leading site for news and procurement in the pharmaceutical industry Wed, 17 Apr 2024 16:04:04 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.2 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png https://www.pharmaceutical-technology.com/news/ 32 32 https://www.pharmaceutical-technology.com/news/igm-and-sanofi-collaboration-will-pivot-to-immunology-and-inflammation/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_1536904274.jpg Wed, 17 Apr 2024 16:04:01 +0000 https://www.pharmaceutical-technology.com/news/igm-and-sanofi-collaboration-will-pivot-to-immunology-and-inflammation/ https://www.pharmaceutical-technology.com/news/lexeo-wins-fast-track-designation-for-friedreichs-ataxia-gene-therapy/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2197321013-e1713366035493.jpg Wed, 17 Apr 2024 15:17:56 +0000 https://www.pharmaceutical-technology.com/news/lexeo-wins-fast-track-designation-for-friedreichs-ataxia-gene-therapy/ https://www.pharmaceutical-technology.com/news/ultimovacs-downsizes-to-funnel-funds-to-cancer-vaccine-programme/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2209421681.jpg Wed, 17 Apr 2024 11:07:21 +0000 https://www.pharmaceutical-technology.com/?p=297208 https://www.pharmaceutical-technology.com/news/alvotech-teva-fda-selarsdi/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/Alvotech.jpg Wed, 17 Apr 2024 10:16:31 +0000 https://www.pharmaceutical-technology.com/news/alvotech-teva-fda-selarsdi/ https://www.pharmaceutical-technology.com/news/johnson-johnson-earnings-q1-2024/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/Johnson-Johnson.jpg Wed, 17 Apr 2024 10:09:49 +0000 https://www.pharmaceutical-technology.com/news/johnson-johnson-earnings-q1-2024/ https://www.pharmaceutical-technology.com/news/tetrascience-google-cloud-partnership/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/TetraScience.jpg Wed, 17 Apr 2024 08:16:41 +0000 https://www.pharmaceutical-technology.com/news/tetrascience-google-cloud-partnership/ https://www.pharmaceutical-technology.com/news/medincell-abbvie-injectable-therapy-deal/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/Medincell.jpg Wed, 17 Apr 2024 08:09:28 +0000 https://www.pharmaceutical-technology.com/news/medincell-abbvie-injectable-therapy-deal/ https://www.pharmaceutical-technology.com/news/jardiance-and-ofev-propel-boehringers-human-pharma-sales/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/Boehringer-image.jpg Tue, 16 Apr 2024 15:20:16 +0000 https://www.pharmaceutical-technology.com/news/jardiance-and-ofev-propel-boehringers-human-pharma-sales/ https://www.pharmaceutical-technology.com/news/acorda-loses-nasdaq-listing-to-cap-biotechs-end/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_1464580457.jpg Tue, 16 Apr 2024 14:51:39 +0000 https://www.pharmaceutical-technology.com/news/acorda-loses-nasdaq-listing-to-cap-biotechs-end/ https://www.pharmaceutical-technology.com/news/two-major-breakthroughs-in-fragile-x-syndrome-treatments/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_2378150581-e1713273712483.jpg Tue, 16 Apr 2024 13:33:24 +0000 https://www.pharmaceutical-technology.com/news/two-major-breakthroughs-in-fragile-x-syndrome-treatments/